You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 582 Patient-reported outcomes with cemiplimab versus chemotherapy in advanced non-small cell lung cancer (aNSCLC): Eastern cooperative oncology group (ECOG) performance status subgroups in EMPOWER-Lung 1

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials Completed
582 Patient-reported outcomes with cemiplimab versus chemotherapy in advanced non-small cell lung cancer (aNSCLC): Eastern cooperative oncology group (ECOG) performance status subgroups in EMPOWER-Lung 1
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022268023
Dec 20224405
Jan 20235006
Feb 20237406
Mar 20235004
Apr 20237604
May 20235803
Jun 20233003
Jul 20235006
Aug 20232003
Sep 20233803
Oct 20234606
Nov 20236806
Dec 20235605
Jan 20242803
Feb 20244404
Mar 202446021
Apr 20242806
May 20241801
Jun 20243804
Jul 202444011
Aug 20242005
Total11940138